Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Discovery and characterization of novel regulators of Apo-B in larval zebrafish
Combined PET and fMRI imaging of dopamine and serotonin responses in depression
Grants for Two Year Programs
Temporal Processing in Cochlear Implants
Desmoglein I in Pathogenesis of Pemphigus Foliaceus
Recently added grants:
Advancing RNA Therapeutics for Huntington?s Disease
Meningeal stem cell signals for improving sensorimotor and cognitive outcomes after stroke
The role of myelination in cortical circuit function and motor behavior
Diffuse Optics for Pediatric Hydrocephalus Management
Novel SMARD1 Mouse Models: Characterization and Evaluation of Potential Therapeutic Targets
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-003
Application #
7191429
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant